Plasma lipids and inflammation in active inflammatory bowel diseases

Alimentary Pharmacology and Therapeutics

Volumn 29, Issue 3, 2009, Pages 298-307

  Romanato, G ^a   Scarpa, M ^b   Angriman, I ^c   Faggian, D ^c   Ruffolo, C ^c   Marin, R ^c   Zambon, S ^c   Basato, S ^c   Zanoni, S ^c   Filosa, T ^c   Pilon, F ^c   Manzato, E ^a,c  

^a CNR   (Italy)

^b VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; C REACTIVE PROTEIN; DOCOSAPENTAENOIC ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; OMEGA 3 FATTY ACID; PHOSPHOLIPID; POLYUNSATURATED FATTY ACID;

ADULT; ARTICLE; BODY MASS; CROHN DISEASE; DIETARY INTAKE; DISEASE ASSOCIATION; ENTERITIS; FEMALE; HARVEY BRADSHAW ACTIVITY INDEX; HUMAN; INFLAMMATION; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCORING SYSTEM; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; BLOOD CHEMICAL ANALYSIS; BODY MASS INDEX; CHOLESTEROL, HDL; CHOLESTEROL, LDL; COLITIS, ULCERATIVE; CROHN DISEASE; CYTOKINES; DIET RECORDS; FEMALE; HUMANS; INTESTINAL ABSORPTION; MALE; MIDDLE AGED; QUESTIONNAIRES; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 58149102213     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2008.03886.x     Document Type: Article

References (50)

1. Levy E, Rizwan Y, Thibault L, et al. Altered lipid profile, lipoprotein composition, and oxidant and antioxidant status in pediatric Crohn disease. Am J Clin Nutr 2000 71 : 807 15.
2. Greenberg AS, Nordan RP, McIntosh J, Calvo JC, Scow RO, Jablons D. Interleukin 6 reduces lipoprotein lipase activity in adipose tissue of mice in vivo and in 3T3-L1 adipocytes: a possible role for interleukin 6 in cancer cachexia. Cancer Res 1992 52 : 4113 6.
3. Hardardottir I, Doerrler W, Feingold KR, Grunfeld C. Cytokines stimulate lipolysis and decrease lipoprotein lipase activity in cultured fat cells by a prostaglandin independent mechanism. Biochem Biophys Res Commun 1992 186 : 237 43.
4. Gil A. Polyunsaturated fatty acids and inflammatory diseases. Biomed Pharmacother 2002 56 : 388 96.
5. Vessby B. Dietary fat, fatty acid composition in plasma and the metabolic syndrome. Curr Opin Lipidol 2003 14 : 15 9.
6. Meydani SN, Endres S, Woods MM, et al. Oral (n-3) fatty acid supplementation suppresses cytokine production and lymphocyte proliferation: comparison between young and older women. J Nutr 1991 121 : 547 55.
7. Thies F, Nebe-von-Caron G, Powell JR, Yaqoob P, Newsholme EA, Calder PC. Dietary supplementation with gamma-linolenic acid or fish oil decreases T lymphocyte proliferation in healthy older humans. J Nutr 2001 131 : 1918 27.
8. Yaqoob P, Pala HS, Cortina-Borja M, Newsholme EA, Calder PC. Encapsulated fish oil enriched in alpha-tocopherol alters plasma phospholipid and mononuclear cell fatty acid compositions but not mononuclear cell functions. Eur J Clin Invest 2000 30 : 260 74.
9. Esteve-Comas M, Ramirez M, Fernandez-Banares F, et al. Plasma polyunsaturated fatty acid pattern in active inflammatory bowel disease. Gut 1992 33 : 1365 9.
10. Esteve-Comas M, Nunez MC, Fernandez-Banares F, et al. Plasma polyunsaturated fatty acid pattern in non-active inflammatory bowel disease. Gut 1993 34 : 1370 3.
11. Shoda R, Matsueda K, Yamato S, Umeda N. Epidemiologic analysis of Crohn disease in Japan: increased dietary intake of n-6 polyunsaturated fatty acids and animal protein relates to the increased incidence of Crohn disease in Japan. Am J Clin Nutr 1996 63 : 741 5.
12. Sanderson P, Calder PC. Dietary fish oil diminishes lymphocyte adhesion to macrophage and endothelial dell mono layers. Immunology 1998 94 : 79 87.
13. Usami M, Komurasaki T, Hanada A, Kinoshita K, Ohata A. Effect of gamma-linolenic acid or docosahexaenoic acid on tight junction permeability in intestinal monolayer cells and their mechanism by protein kinase C activation and/or eicosanoid formation. Nutrition 2003 19 : 150 6.
14. Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol 1989 170 : 2 6.
15. Harvey RF, Bradshaw JM. A simple index of Crohn's disease activity. Lancet 1980 1 : 514.
16. Kane SV, Sandborn WJ, Rufo PA, et al. Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation. Am J Gastroenterol 2003 98 : 1309 14.
17. Carnovale E, Marletta L. Tabella di composizione degli alimenti. In : Edra, ed. Table on Feed Chemical Composition. Milan, Italy : Istituto Nazionale della Nutrizione, 1997.
18. Atlante ragionato di alimentazione. In : ISTITUTO SCOTTI BASSANI per la Ricerca e l'informazione scientifica e nutrizionale, ed. Milano, Italy : 1997.
19. Southgate DA, Greenfield H. Principles for the preparation of nutritional data bases and food composition tables. World Rev Nutr Diet 1992 68 : 27 48.
20. Roschlau P, Bernt E, Gruber W. Enzymatische bestimmung des gesamtcholesterins im serum. Klin Chem Klin Biochem 1974 12 : 403 7.
21. Wahlefeld AW. Triglycerides determination after enzymatic hydrolysis. In : Bergmeyer HU, ed. Methods of Enzymatic Analysis. New York : Academic Press, 1976 : 1831 5.
22. Lipid Research Clinics Program. Lipid and lipoprotein analysis. In : NIH, ed. Manual of Laboratory Operations, 2nd edn. Washington, DC : US Department of Health and Human Service, 1982 : 63 77.
23. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972 18 : 499 502.
24. Folch J, Lees M, Stanley GHS. A single method for the isolation and purification of total lipids from animal tissue. J Biol Chem 1957 226 : 497 507.
25. Morrison WR, Smith LM. Preparation of fatty acid methyl esters and dimethylacetals from lipids with boron fluoride-methanol. J Lipid Res 1964 5 : 600 8.
26. Fong Y, Lowry SF. Cytokines and cellular response to injury and infection. In : Harken AH, Wilmore DW, eds. Care of the Surgical Patient. Sci Am 1996 Suppl. 1 21.
27. Piquer BR, Nazih H, Bourreille A, et al. Altered lipid, apolipoprotein, and lipoprotein profiles in inflammatory bowel disease: consequences on the cholesterol efflux capacity of serum using Fu5AH cell system. Metabolism, 2006 55 : 980 8.
28. Sammalkorpi KT, Valtonen VV, Maury CP. Lipoproteins and acute phase response during acute infection. Interrelationships between C-reactive protein and serum amyloid-A protein and lipoproteins. Ann Med 1990 22 : 397 401.
29. Artl A, Marsche G, Pussinen P, Knipping G, Sattler W, Malle E. Impaired capacity of acute-phase high density lipoprotein particles to deliver cholesteryl ester to the human HUH-7 hepatoma cell line. Int J Biochem Cell Biol 2002 34 : 370 81.
30. Calder PC. Polyunsaturated fatty acids and inflammation. Prostaglandins Leukot Essent Fatty Acids 2006 75 : 197 202.
31. Gibney MJ, Hunter B. The effects of short- and long-term supplementation with fish oil on the incorporation of n-3 polyunsaturated fatty acids into cells of the immune system in healthy volunteers. Eur J Clin Nutr 1993 47 : 255 9.
32. Geerling BJ, v Houwelingen AC, Badart-Smook A, Stockbrugger RW, Brummer RJ. Fat intake and fatty acid profile in plasma phospholipids and adipose tissue in patients with Crohn's disease, compared with controls. Am J Gastroenterol 1999 94 : 410 7.
33. Trebble TM, Arden NK, Wootton SA, et al. Peripheral blood mononuclear cell fatty acid composition and inflammatory mediator production in adult Crohn's disease. Clin Nutr 2004 23 : 647 55.
34. Trebble TM, Wootton SA, May A, et al. Essential fatty acid status in paediatric Crohn's disease: relationship with disease activity and nutritional status. Aliment Pharmacol Ther 2003 18 : 433 42.
35. Figler M, Gasztonyi B, Cseh J, et al. Association of n-3 and n-6 long-chain polyunsaturated fatty acids in plasma lipid classes with inflammatory bowel diseases. Br J Nutr 2007 97 : 1154 61.
36. Geerling BJ, v Houwelingen AC, Badart-Smook A, Stockbrugger RW, Brummer RJ. The relation between antioxidant status and alterations in fatty acid profile in patients with Crohn disease and controls. Scand J Gastroenterol 1999 34 : 1108 16.
37. Endres S, Ghorbani R, Kelley VE, et al. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med 1989 320 : 265 71.
38. Stenson WF. Role of eicosanoids as mediators of inflammation in inflammatory bowel disease. Scand J Gastroenterol Suppl 1990 172 : 13 8.
39. Lopez-Garcia E, Schulze MB, Manson JE, et al. Consumption of (n-3) fatty acids is related to plasma biomarkers of inflammation and endothelial activation in women. J Nutr 2004 134 : 1806 11.
40. De Caterina R, Cybulsky MI, Clinton SK, Gimbrone MA Jr., Libby P. The omega-3 fatty acid docosahexaenoate reduces cytokine-induced expression of proatherogenic and proinflammatory proteins in human endothelial cells. Arterioscler Thromb 1994 14 : 1829 36.
41. Khalfoun B, Thibault F, Watier H, Bardos P, Lebranchu Y. Docosahexaenoic and eicosapentaenoic acids inhibit in vitro human endothelial cell production of interleukin-6. Adv Exp Med Biol 1997 400B : 589 97.
42. Chavali SR, Zhong WW, Forse RA. Dietary alpha-linolenic acid increases TNF-alpha, and decreases IL-6, IL-10 in response to LPS: effects of sesamin on the delta-5 desaturation of omega6 and omega3 fatty acids in mice. Prostaglandins Leukot Essent Fatty Acids 1998 58 : 185 91.
43. Baumann H, Gauldie J. Regulation of hepatic acute phase plasma protein genes by hepatocyte stimulating factors and other mediators of inflammation. Mol Biol Med 1990 7 : 147 59.
44. Yamada T. Serum amyloid A (SAA): a concise review of biology, assay methods and clinical usefulness. Clin Chem Lab Med 1999 37 : 381 8.
45. Rallidis LS, Paschos G, Liakos GK, Velissaridou AH, Anastasiadis G, Zampelas A. Dietary alpha-linolenic acid decreases C-reactive protein, serum amyloid A and interleukin-6 in dyslipidaemic patients. Atherosclerosis 2003 167 : 237 42.
46. Bemelmans WJ, Lefrandt JD, Feskens EJ, et al. Increased alpha-linolenic acid intake lowers C-reactive protein, but has no effect on markers of atherosclerosis. Eur J Clin Nutr 2004 58 : 1083 9.
47. King DE, Egan BM, Geesey ME. Relation of dietary fat and fiber to elevation of C-reactive protein. Am J Cardiol 2003 92 : 1335 9.
48. De Caterina R, Liao JK, Libby P. Fatty acid modulation of endothelial activation. Am J Clin Nutr 2000 71 : 213S 23S.
49. Lee JY, Sohn KH, Rhee SH, Hwang D. Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4. J Biol Chem 2001 276 : 16683 9.
50. Jeppesen PB, Høy CE, Mortensen PB. Differences in essential fatty acid requirements by enteral and parenteral routes of administration in patients with fat malabsorption. Am J Clin Nutr 1999 70 : 78 84.